Neurocrine Bioscience buy Royal Bank of Canada
Start price
02.06.25
/
50%
€108.85
Target price
02.06.26
€127.53
Performance (%)
3.35%
Price
13.08.25
€112.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 3.35%. This prediction currently runs until 02.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.180% | 2.180% |
| iShares Core DAX® | 1.043% | -0.149% |
| iShares Nasdaq 100 | 1.920% | 4.604% |
| iShares Nikkei 225® | 4.840% | 8.328% |
| iShares S&P 500 | 1.567% | 3.310% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $145.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
0.04%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
6.23%
13.08.25
13.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
34.92%
13.08.25
13.08.25